The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Savlevich E.L.

Training Scientific Medical Center of the Russian Federation Presidential Administration, Moscow, Russia, 121359

Kozlov V.S.

Kafedra otorinolaringologii FGBU UNMTs UD Prezidenta RF

Kurbacheva O.M.

Institute of Immunology, Federal Medico-Biological Agency, Moscow, Russia, 115478

The modern trends in the diagnostic search for and the treatment of chronic rhinosinusitis with nasal polyps

Authors:

Savlevich E.L., Kozlov V.S., Kurbacheva O.M.

More about the authors

Journal: Russian Rhinology. 2018;26(2): 41‑47

DOI: 10.17116/rosrino201826241

Views: 1147

Downloaded: 67

Download PDF (RU)
Contact the author
Table of contents

THE MODERN TRENDS IN THE DIAGNOSTIC SEARCH FOR AND THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
THE MODERN TRENDS IN THE DIAGNOSTIC SEARCH FOR AND THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

To cite this article:

Savlevich EL, Kozlov VS, Kurbacheva OM. The modern trends in the diagnostic search for and the treatment of chronic rhinosinusitis with nasal polyps. Russian Rhinology. 2018;26(2):41‑47. (In Russ.)
https://doi.org/10.17116/rosrino201826241

Подписка 2025-2 (Russian Rhinology)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Comparative evaluation of functional and clinical indi­cators of nasal obstruction and cognitive tests in patients with chro­nic rhinosinusitis with nasal polyps. Russian Rhinology. 2024;(2):104-110
Chro­nic rhinosinusitis with nasal polyps as the first stage in the deve­lopment of eosi­nophilic granulomatosis with polya­ngiitis. Russian Rhinology. 2024;(2):157-166
Clinical obse­rvation of the course of eosi­nophilic otitis media against the background of biological therapy of chro­nic poly­pous rhinosinusitis. Russian Bulletin of Otorhinolaryngology. 2024;(2):95-100
Therapeutic physical factors in correction of systemic mechanisms of como­rbidity in patients with poly­pous rhinosinusitis. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(1):5-12
Clinical and epidemiological characteristics of bronchial asthma and chro­nic obstructive pulmonary disease inci­dence in Russia before and during the COVID-19 epidemy. Russian Journal of Preventive Medi­cine. 2024;(6):42-48
Features of inflammatory endo­types and phenotypes in chro­nic rhinosinusitis. Russian Bulletin of Otorhinolaryngology. 2024;(4):60-67
Modern pathogenetic treatment of rare demye­linating diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):33-36
«Cytokine storm» as an immu­nopathologic reaction in pregnant women in the first trimester. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):19-24
Esophageal pathology and bronchial asthma: pathogenetic inte­ractions and possibilities for therapy opti­mization. Russian Journal of Preventive Medi­cine. 2024;(11):129-134
Anti­fungal immu­nity in patients with chro­nic rhinosinusitis with nasal polyps. Russian Bulletin of Otorhinolaryngology. 2024;(6):40-45

The problem of understanding the causes for the development of chronic rhinosinusitis with nasal polyps (CRSwNP) remains to be elucidated. Heterogeneity of CRSwNP development can be explained by different molecular and cellular pathways which lead to inflammation of the mucous membrane followed by its further remodelling. The recurrence of the polypous process is observed in 60—70% of the cases within 18 months after functional endoscopic surgical intervention on the nasal sinuses (FESS). The ongoing investigations have the objective to elaborate the fundamentally new methods for targeted therapy aimed at a specific biological substrate. The main difficulty encountered in the correct selection of the proper medications is to determine the most significant key biomarker at the molecular level in a particular patient, such the blockade of which would lead to regression of the pathological process. At present, monoclonal antibodies to IL-5, 13, IgE, alpha-chain of the IL-4 receptor, transmembrane receptor Siglec-8, transcription factor GATA-3 specific DNA enzyme are being developed and introduced in the clinical practice.

Keywords:

chronic rhinosinusitis with nasal polyps
endotypes
monoclonal antibodies
interleukins
bronchial asthma

Authors:

Savlevich E.L.

Training Scientific Medical Center of the Russian Federation Presidential Administration, Moscow, Russia, 121359

Kozlov V.S.

Kafedra otorinolaringologii FGBU UNMTs UD Prezidenta RF

Kurbacheva O.M.

Institute of Immunology, Federal Medico-Biological Agency, Moscow, Russia, 115478

List of references:

  1. Lal D, Scianna JM, Stankiewicz JA. Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure. American Journal of RhinoÂlogy & Allergy. 2009;23(4):396-400. https://doi.org/10.2500/ajra.2009.23.3334
  2. Vlaminck S, Vauterin T, Hellings PW, Jorissen M, Acke F, Van Cauwenberge P, Bachert C, Gevaert P. The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis: a 3-year prospective observational study. American Journal of Rhinology & Allergy. 2014;28(3):260-264. https://doi.org/10.1186/2045-7022-3-s2-o12
  3. Kirdeeva AI, Kosyakov SYa. The peculiarities of endotyping and phenotyping of chronic rhinosinusitis. Russian rhinology. 2017;25(2):58-63. (In Russ.) https://doi.org/10.17116/rosrino201725258-63
  4. Dennis SK, Lam K, Luong A. A review of classification schemes for chroÂnic rhinosinusitis with nasal polyposis endotypes. Laryngoscope Investig Otolaryngol. 2016;1(5):130-134. https://doi.org/10.1002/lio2.32
  5. Savlevich EL, Simbirtsev AS, Bondareva GP, Kurbacheva OM. Role of cytokines in the development of chronic rhinosinusitis with polyps. Cytokines and inflammation. 2016;15(3-4):265-268. (In Russ.)
  6. Pavlova KS, Kurbacheva OM, Galitskaya MA, Smirnov DS. Actual conception of allergen-specific immunotherapy mechanisms, potential biomarkers of efficacy and ways of enhancement. Russian Journal of Allergy. 2017;4-5(14):5-17. (In Russ.)
  7. Khaidukov SV. Minor subsets of t-helper cells (Th thymic naive, Th central naive, Th9, Th22 and CD4+CD8+ double positive t-cells). Medical Immunology. 2014;15(6):503-512. (In Russ.) https://doi.org/10.15789/1563-0625-2013-6-503-512
  8. Kim DW, Cho SH. Emerging endotypes of chronic rhinosinusitis and its application to precision medicine. Allergy, Asthma & Immunology Research. 2017;9(4):299-306. https://doi.org/10.4168/aair.2017.9.4.299
  9. Pant H, Hughes A, Schembri M, Miljkovic D, Krumbiegel D. CD4+ and CD8+ regulatory T cells in chronic rhinosinusitis mucosa. American Journal of Rhinology & Allergy. 2014;28(2):83-89. https://doi.org/10.2500/ajra.2013.28.4014
  10. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, Bachert C. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61(11):1280-1289. https://doi.org/10.1111/j.1398-9995.2006.01225.x
  11. Wang X, Zhang N, Bo M, Holtappels G, Zheng M, Lou H, Wang H, Zhang L, Bachert C. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. Journal of Allergy and Clinical Immunology. 2016;138(5):1344-1353. https://doi.org/10.1016/j.jaci.2016.05.041
  12. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, Wang de Y, Wormald PJ. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;50(23):1-298. https://doi.org/10.4193/Rhino50E2
  13. Kozlov VS, Savlevich EL. Chronic rhinosinusitis with nasal polyps. The recent trend in the studies of the pathogenesis, diagnosis and treatment of this disease. Vestnik otorinolaringologii. 2015;80(4):95-99. (In Russ.) https://doi.org/10.17116/otorino201580495-99
  14. DeConde AS, Mace JC, Levy JM, Rudmik L, Alt JA, Smith TL. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. The Laryngoscope. 2016;127(3):550-555. https://doi.org/10.1002/lary.26391
  15. Ivanov AA, Beletskii IP. Therapy with monoclonal antibodies is a panacea or palliative? Remedium. 2011;3:12-16. (In Russ.)
  16. Lam K, Kern RC, Luong A. Is there a Future for Biologics in the Management of Chronic Rhinosinusitis? International Forum of Allergy & Rhinology. 2016;6(9):935-942. https://doi.org/10.1002/alr.21780
  17. Ba L, Zhang N, Meng J, Zhang J, Lin P, Zhou P, Liu S, Bachert C. The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polyps. Allergy. 2011;66(10):1296-1303. https://doi.org/10.1111/j.1398-9995.2011.02637.x
  18. Tokunaga T, Sakashita M, Haruna T, Asaka D, Takeno S, Ikeda H, Nakayama T, Seki N, Ito S, Murata J, Sakuma Y, Yoshida N, Terada T, Morikura I, Sakaida H, Kondo K, Teraguchi K, Okano M, Otori N, Yoshikawa M, Hirakawa K, Haruna S, Himi T, Ikeda K8, Ishitoya J, Iino Y, Kawata R, Kawauchi H, Kobayashi M, Yamasoba T, Miwa T, Urashima M, Tamari M18, Noguchi E, Ninomiya T, Imoto Y, Morikawa T, Tomita K, Takabayashi T, Fujieda S. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study. Allergy. 2015;70(8):995-1003. https://doi.org/10.1111/all.12644
  19. Zhang N, Van Crombruggen K, Gevaert E, Bachert C. Barrier function of the nasal mucosa in health and type-2 biased airway diseases. Allergy. 2016;71(3):295-307. https://doi.org/10.1111/all.12809
  20. Blanchard C, Mingler MK, McBride M, Putnam PE, Collins MH, Chang G, Stringer K, Abonia JP, Molkentin JD, Rothenberg ME. Periostin facilitates eosinophil tissue infiltrati on in allergic lung and esophageal responses. Mucosal Immunology. 2008;1(4):289-296. https://doi.org/10.1038/mi.2008.15
  21. Asano T, Kanemitsu Y, Takemura M, Yokota M, Fukumitsu K, Takeda N, Ichikawa H, Uemura T, Takakuwa O, Ohkubo H, Maeno K, Ito Y, Oguri T, Maki Y, Ono J, Ohta S, Nakamura Y, Izuhara K, Suzuki M, Niimi A. Serum periostin as a biomarker for comorbid chronic rhinosinusitis in patients with asthma. Annals of the American Thoracic Society. 2017;14(5):667-675. https://doi.org/10.1513/annalsats.201609-720oc
  22. Miłoński J, Zielińska-Bliźniewska H, Przybyłowska K, Pietkiewicz P, Korzycka-Zaborowska B, Majsterek I, Olszewski J. Significance of cyclooxygenase-2 (COX-2), periostin (POSTN) and interleukin-4 (IL-4) gene expression in the pathogenesis of chronic rhinosinusitis with nasal polyps. European Archives of Oto-Rhino-Laryngology. 2015;272(12):3715-3720. https://doi.org/10.1007/s00405-014-3481-9
  23. Ueki S, Konno Y, Takeda M, Moritoki Y, Hirokawa M, Matsuwaki Y, Honda K, Ohta N, Yamamoto S, Takagi Y, Wada A, Weller PF. Eosinophil extracellular trap cell death-derived DNA traps: Their presence in secretions and functional attributes. Journal of Allergy and Clinical Immunology. 2016;137(1):258-267. https://doi.org/10.1016/j.jaci.2015.04.041
  24. Morshed M, Yousefi S, Stöckle C, Simon HU, Simon D. Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps. Allergy. 2012;67(9):1127-1137. https://doi.org/10.1111/j.1398-9995.2012.02868.x
  25. Gevaert E, Zhang N, Krysko O, Lan F, Holtappels G, De Ruyck N, Nauwynck H, Yousefi S, Simon HU, Bachert C. Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation. Journal of Allergy and Clinical Immunology. 2017;139(6):1849-1860. https://doi.org/10.1016/j.jaci.2017.01.019
  26. Wen W, Liu W, Zhang L, Bai J, Fan Y, Xia W, Luo Q, Zheng J, Wang H, Li Â Z, Xia J, Jiang H, Liu Z, Shi J, Li H, Xu G. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. Journal of Allergy and Clinical Immunology. 2012;129(6):1522-1528. https://doi.org/10.1016/j.jaci.2012.01.079
  27. Schleimer RP, Schnaar RL, Bochner BS. Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression. Current Opinion in Allergy and Clinical Immunology. 2016;16(1):24-30. https://doi.org/10.1097/aci.0000000000000234
  28. Yokoi H, Choi OH, Hubbard W, Lee HS, Canning BJ, Lee HH, Ryu SD, von Gunten S, Bickel CA, Hudson SA, Macglashan DW Jr, Bochner BS. Inhibition of FcεRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. Journal of Allergy and Clinical Immunology. 2008;121(2):499-505. https://doi.org/10.1016/j.jaci.2007.10.004
  29. Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, De Ruyck N, Blomme K, Sousa AR, Marshall RP, Bachert C. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. Journal of Allergy and Clinical Immunology. 2011;128(5):989-995. https://doi.org/10.1016/j.jaci.2011.07.056
  30. Van Crombruggen K, Zhang N, Gevaert P, Tomassen P, Bachert C. Pathogenesis of chronic rhinosinusitis: inflammation. Journal of Allergy and CliÂnical Immunology. 2011;128(4):728-732. https://doi.org/10.1016/j.jaci.2011.07.049
  31. Kim CK. Eosinophil-derived neurotoxin: a novel biomarker for diagnosis and monitoring of asthma. Korean Journal of Pediatrics. 2013;56(1):8-12. https://doi.org/10.3345/kjp.2013.56.1.8
  32. Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H, Förster-Ruhrmann U, Kowalski ML, Olszewska-Ziąber A, Holtappels G, De Ruyck N, Wang X, Van Drunen C, Mullol J, Hellings P, Hox V, Toskala E, Scadding G, Lund V, Zhang L, Fokkens W, Bachert C. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. Journal of Allergy and Clinical Immunology. 2016;137(5):1449-1456. https://doi.org/10.1016/j.jaci.2015.12.1324
  33. Laviolette M, Gossage DL, Gauvreau G, Leigh R, Olivenstein R, Katial R, Busse WW, Wenzel S, Wu Y, Datta V, Kolbeck R, Molfino NA. Effects of benralizumab on airway eosinophils in asthma with sputum eosinophilia. Journal of Allergy and Clinical Immunology. 2013;132(5):1086-1096. https://doi.org/10.1016/j.jaci.2013.05.020
  34. Ketlinskii SA, Simbirtsev AS. Cytokines and inflammation. SPb.: Foliant; 2008. (In Russ.)
  35. Bachert C, Mannent L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P, Hellings P, Jiao L, Wang L, Evans RR, Pirozzi G, Graham NM, Swanson B, Hamilton JD, Radin A, Gandhi NA, Stahl N, Yancopoulos GD, Sutherland ER. Effect of subcutaneous Dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315(5):469-479. https://doi.org/10.1001/jama.2015.19330
  36. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG. Lebrikizumab treatment in adults with asthma. New England Journal of Medicine. 2011;365(12):1088-1098. https://doi.org/10.1056/nejmoa1106469
  37. Brightling CE, Chanez P, Leigh R, O’Byrne PM, Korn S, She D, May RD, Streicher K, Ranade K, Piper E. Efficacy and safety of Tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial. The Lancet Respiratory Medicine. 2015;3(9):692-701. https://doi.org/10.1016/s2213-2600(15)00197-6
  38. Nixon J, Newbold P, Mustelin T, Anderson GP, Kolbeck R. Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation. Pharmacology & Therapeutics. 2017;169:57-77. https://doi.org/10.1016/j.pharmthera.2016.10.016
  39. Ebenezer JA, Christensen JM, Oliver BG, Oliver RA, Tjin G, Ho J, Habib  AR, Rimmer J, Sacks R, Harvey RJ. Periostin as a marker of mucosal remodelling in chronic rhinosinusitis. Rhinology. 2017;55(3):234-241. https://doi.org/10.4193/rhin16.215
  40. Sheahan P, Ahn CN, Harvey RJ, Wise SK, Mulligan RM, Lathers DM, Schlosser RJ. Local IgE production in nonatopic nasal polyposis. J Otolaryngol Head Neck Surg. 2010;39(1):45-51.
  41. Kato A, Peters A, Suh L, Carter R, Harris KE, Chandra R, Conley D, Grammer LC, Kern R, Schleimer RP. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology. 2008;121(6):1385-1392. https://doi.org/10.1016/j.jaci.2008.03.002
  42. Tan BK, Li QZ, Suh L, Kato A, Conley DB, Chandra RK, Zhou J, Norton J, Carter R, Hinchcliff M, Harris K, Peters A, Grammer LC, Kern RC, Mohan C, Schleimer RP. Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology. 2011;128(6):1198-1206. https://doi.org/10.1016/j.jaci.2011.08.037
  43. Bachert C, Zhang N, Van Zele T, Gevaert P, Patou J, Van Cauwenberge P. Staphylococcus aureus enterotoxins as immune stimulants in chronic rhinosinusitis. Clin Allergy Immunol. 2007;20:163-175.
  44. Hanania NA, Wenzel S, Rosén K, Hsieh HJ, Mosesova S, Choy DF, Lal P, Arron JR, Harris JM, Busse W. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med. 2013;187(8):804-811. https://doi.org/10.1164/rccm.201208-1414oc
  45. Pinto JM, Mehta N, DiTineo M, Wang J, Baroody FM, Naclerio RM. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010;48(3):318-324. https://doi.org/10.4193/rhin09.144
  46. Kim DW, Kulka M, Jo A, Eun KM, Arizmendi N, Tancowny BP, Hong SN, Lee JP, Jin HR, Lockey RF, Kim DK, Cho SH. Cross-talk between human mast cells and epithelial cells by IgE-mediated periostin production in eosinophilic nasal polyps. Journal of Allergy and Clinical Immunology. 2017;139(5):1692-1695. https://doi.org/10.1016/j.jaci.2016.09.026
  47. Gauvreau GM, Arm JP, Boulet LP, Leigh R, Cockcroft DW, Davis BE, Mayers I, FitzGerald JM, Dahlen B, Killian KJ, Laviolette M, Carlsten C, Lazarinis N, Watson RM, Milot J, Swystun V, Bowen M, Hui L, Lantz AS, Meiser K, Maahs S, Lowe PJ, Skerjanec A, Drollmann A, O’Byrne PM. Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses. Journal of Allergy and Clinical Immunology. 2016;138(4):1051-1059. https://doi.org/10.1016/j.jaci.2016.02.027
  48. Sel S, Wegmann M, Dicke T, Sel S, Henke W, Yildirim AO, Renz H, Garn H. Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme. Journal of Allergy and Clinical Immunology. 2008;121(4):910-916. https://doi.org/10.1016/j.jaci.2007.12.1175
  49. Krug N, Hohlfeld JM, Kirsten AM, Kornmann O, Beeh KM, Kappeler D, Korn S, Ignatenko S, Timmer W, Rogon C, Zeitvogel J, Zhang N, Bille J, Homburg U, Turowska A, Bachert C, Werfel T, Buhl R, Renz J, Garn H, Renz H. Allergen-induced asthmatic responses modified by a GATA-3-specific DNAzyme. New England Journal of Medicine. 2015;372(21):1987-1995. https://doi.org/10.1056/nejmoa1411776

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.